RNASEL R462Q Mutation in Prostate Cancer

authors:

avatar Xiuping Yu 1 , avatar Robert J. Matusik 2 , avatar Renjie Jin 2 , *

Health Sciences Center, Louisiana State University, Shreveport, USA
Department of Urologic Surgery and Vanderbilt Prostate Cancer Center, Vanderbilt University Medical Center, Nashville, USA
Gene, Cell and Tissue: Vol.2, issue 1; e60170
published online: November 25, 2014
article type: Letter
received: October 8, 2014
revised: October 21, 2014
accepted: October 28, 2014
DOI: https://doi.org/10.17795/gct-24411

how to cite: Yu X, Matusik R J, Jin R. RNASEL R462Q Mutation in Prostate Cancer. Gene Cell Tissue. 2015;2(1):e60170. https://doi.org/10.17795/gct-24411.

References

  • 1.

    Thompson D, Easton DF, Breast Cancer Linkage C. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002;94(18):1358-65. [PubMed ID: 12237281].

  • 2.

    Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol. 2004;22(4):735-42. [PubMed ID: 14966099]. https://doi.org/10.1200/JCO.2004.05.055.

  • 3.

    Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012;366(2):141-9. [PubMed ID: 22236224]. https://doi.org/10.1056/NEJMoa1110000.

  • 4.

    Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 2002;30(2):181-4. [PubMed ID: 11799394]. https://doi.org/10.1038/ng823.

  • 5.

    Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(2):e19169.

  • 6.

    Brennan-Laun SE, Ezelle HJ, Li XL, Hassel BA. RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. J Interferon Cytokine Res. 2014;34(4):275-88. [PubMed ID: 24697205]. https://doi.org/10.1089/jir.2013.0147.

  • 7.

    Karyadi DM, Zhao S, He Q, McIntosh L, Wright JL, Ostrander EA, et al. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. Int J Cancer. 2014. [PubMed ID: 25273821]. https://doi.org/10.1002/ijc.29241.

  • 8.

    Bettoun DJ, Scafonas A, Rutledge SJ, Hodor P, Chen O, Gambone C, et al. Interaction between the androgen receptor and RNase L mediates a cross-talk between the interferon and androgen signaling pathways. J Biol Chem. 2005;280(47):38898-901. [PubMed ID: 16166078]. https://doi.org/10.1074/jbc.C500324200.

  • 9.

    Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, et al. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res. 2013;19(6):1612-9. [PubMed ID: 23382116]. https://doi.org/10.1158/1078-0432.CCR-12-2718.